SCI Abstract

search
Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in France
Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in France
Influenza in France causes, on average, more than 1 million primary care consultations, 20,000 hospitalizations, and 9000 ...
Deep Learning for the Early Diagnosis of Candidemia
Deep Learning for the Early Diagnosis of Candidemia
Candidemia carries a heavy burden in terms of mortality, especially when presenting as septic shock, and its early diagnos...
Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices
Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices
Ceftobiprole medocaril is a new fifth-generation cephalosporin commercially available as a prodrug. Since it is newly intr...
Cost-Effectiveness Analysis of a Bivalent RSVPreF Vaccine in Japanese Adults Aged 60 Years and Older
Cost-Effectiveness Analysis of a Bivalent RSVPreF Vaccine in Japanese Adults Aged 60 Years and Older
Respiratory syncytial virus (RSV) is a major cause of acute respiratory illness. A bivalent RSV prefusion F protein-based ...
Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period
Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period
Long-acting cabotegravir/rilpivirine (LA-CAB/RPV) offers an effective alternative to daily oral antiretroviral therapy (AR...
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada
Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada
Adolescents and young adults are among those most often impacted by invasive meningococcal disease (IMD), and survivors ar...
Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent  Infection in the United States
Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Infection in the United States
Fecal microbiota spores, live-brpk (hereafter VOS) is a microbiota-based orally administered therapeutic approved by the U...
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-to-moderate COVID-19 and at high risk o...
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
In Argentina, vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysac...